Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Seniors Covered In New Medicare Policy For Bariatric Surgery

This article was originally published in The Gray Sheet

Executive Summary

Reversing its November proposal, CMS has decided to include patients aged 65 and older in its national coverage of bariatric surgery for the treatment of morbid obesity

You may also be interested in...



Obesity Device Makers Debate Merits Of CMS Gastric Sleeve Coverage Proposal

Allergan and Johnson & Johnson have differing responses to the Medicare agency’s proposal to require clinical trial participation in return for coverage of a laparoscopic sleeve gastrectomy procedure to treat obesity.

CMS Obesity Coverage Proposal Includes Sunset Deadlines For CED Studies

Under a proposal, the Medicare agency would cover laparoscopic sleeve gastrectomy as a weight-loss surgery option only for patients enrolled in a qualifying clinical trial. In a new approach, CMS puts end dates on when coverage-with-evidence-development studies need to be approved and completed.

CMS Obesity Coverage Proposal Includes Sunset Deadlines For CED Studies

Under a proposal, the Medicare agency would cover laparoscopic sleeve gastrectomy as a weight-loss surgery option only for patients enrolled in a qualifying clinical trial. In a new approach, CMS puts end dates on when coverage-with-evidence-development studies need to be approved and completed.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023271

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel